/

Enliven Therapeutics

Develops small molecule inhibitors for precision oncology treatments.

BiotechnologyPharmaceuticals enliventherapeutics.com ↗

Company facts

Founded: 2019
Employees: 65
Headquarters: United States
Type: Public
Listed: NASDAQ: ELVN